Cancer Genetics is a precision and translational medicine company that offers proprietary preclinical test systems through its vivoPharm subsidiary. These test systems are highly valued by the pharmaceutical industry, biotech companies, and academic research centers in the early stages of clinical diagnostics. The company's focus is on driving drug discovery and developing novel therapies. vivoPharm conducts tailored studies guiding drug development from compound libraries to in vitro and in vivo data to support Investigational New Drug filings. The subsidiary operates in AAALAC accredited and GLP compliant audited facilities.
Cancer Genetics, Inc.'s ticker is CGIX
The company's shares trade on the NASDAQ stock exchange
They are based in Rutherford, New Jersey
There are 51-200 employees working at Cancer Genetics, Inc.
It is https://www.cancergenetics.com/
Cancer Genetics, Inc. is in the Healthcare sector
Cancer Genetics, Inc. is in the Biotechnology industry
The following five companies are Cancer Genetics, Inc.'s industry peers: